Pamela P Palmer
CIK 1511365 · Chief Medical Officer · last filed 2024-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$76.9K
Companies
2
Total Filings
35
Lifetime Open-Market Net
$204.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Chief Medical Officer | 59,149 | $1.30 | $76.9K | $0 | 3 | 2024-03-04 |
| TALPHERA, INC. (ACRX) Delisted | Chief Medical Officer | 38,195 | $0.86 | $32.8K | $204.0K | 30 | 2023-08-25 |
Recent Filings · Page 3 of 4
35 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-19 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | +16,000 | $49.1K | EDGAR |
| 2018-11-05 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-06 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | +37,000 | $101.8K | EDGAR |
| 2018-01-26 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-22 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | +10,000 | $29.5K | EDGAR |
| 2017-02-09 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-18 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-21 | TALPHERA, INC. (ACRX) Delisted | Exer (M) | +29,000 | $74.2K | EDGAR |
| 2015-03-17 | TALPHERA, INC. (ACRX) Delisted | Exer (M) | +25,000 | $33.0K | EDGAR |
| 2014-12-04 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.